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PINK SLIP INTRODUCTION
DENA S. DAVIS1
Is there a pink slip in your genes? In this cleverly worded phrase, Paul Miller
adroitly captures the fears of millions of Americans as we ponder whether the
genetic revolution bodes us well or ill. The Human Genome Project (HGP), which
completed its first phase in 2000, succeeded in mapping the entire human genome, a
breathtaking accomplishment. Scientists promise that, in the future, genetic
knowledge will enable us to fight cancer, treat hitherto intractable genetic diseases,
create drugs perfectly calibrated to the needs of the individual recipient, come up
with vaccines to fight new epidemics, and other wonders. But meanwhile, while we
await these promised miracles, the primary accomplishments of genetic research
have been to identify, rather than to treat. We can identify Tay-Sachs carriers, but
we cannot treat Tay-Sachs. We know that some women are at increased risk of
breast and ovarian cancer because of their genetic make-up, but we can offer them
little more than increased surveillance and prophylactic surgery. We increasingly
accept the notion that almost every health condition has a genetic component, but
treatments and prophylaxis remain virtually unchanged.
What has changed, however, is the degree of worry and concern that people feel
about the uses to which their genetic information can be put. When the HGP began,
a number of pundits were convinced that the “future knowledge” that genetic
information can deliver to consumers and insurers alike would completely
undermine the practice of private health insurance, and send our current system
crashing to the ground. Needless to say, that has not happened; but with 42 million
Americans currently without health insurance, and with insurance tightly entwined
with employment, many people fear that genetic information will be used by
employers and insurers to discriminate against those who appear to present higher
risks.
For most people, the HGP appears like an abstract and distant enterprise. It is
not, hard, however, to imagine scenarios that are anything but abstract and distant.
My mother died of Huntington Disease. Will any one want to hire me,
knowing there is a fifty percent risk that I will have HD as well? My
spouse and I carry sickle cell trait. Although we are healthy, we risk
having children with sickle cell disease. Can we get health insurance? If
we have jobs with insurance, can we afford to move, knowing that a new
employer might not want to add potentially expensive employees to the
group insurance pool? My sister was just diagnosed with breast cancer.
I’d like to have my own genetic risk analyzed, but I am afraid that, if the
news is bad, my insurer will somehow get hold of it and cancel my
coverage just when I need it most. I’d like to take part in a new research
project focusing on genetic diseases associated with my ethnic group
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because I hope that in the long run it would benefit a lot of people, but I
worry that my private information will get into the wrong hands.
In the December 2001 conference at Cleveland-Marshall College of Law, titled Is
There a Pink Slip in Your Genes? Genetic Discrimination in Employment and Health
Insurance, we tried to grapple with these questions. Thoughtful speakers addressed
topics such as our current state of genetic knowledge; whether genetic discrimination
exists; whether litigation, legislation, healthcare reform or some mixture of these
approaches offers the best promise of combating discrimination; whether the
Americans with Disabilities Act is a strong shield against such discrimination, and
the very meaning of “disability” in this new age of genetic knowledge. We are
grateful to all who participated, and in this symposium issue of The Journal of Law
and Health, we invite our readers to share the fruits of this endeavor.

